To evaluate the scope of once-daily dosing of intravenous aminoglycosi
de antibiotics, a questionnaire was designed and mailed to a random sa
mple of pharmacy directors at 500 acute care hospitals in the United S
tates. The response rate was 68.4%. Nineteen percent of the respondent
s reported use of once-daily dosing of aminoglycosides. Affiliation wi
th a pharmacy residency program and the presence of a pharmacokinetic
consultation service by the pharmacy department were associated with t
his practice (p<0.05). No other statistically significant differences
were found. Reported indications, contraindications, and dosing were c
onsistent with those found in the literature. The profession of pharma
cy, as demonstrated by pharmacy residency programs and pharmacokinetic
consultation services, appears to have been instrumental in implement
ing this method of dosing aminoglycosides.